Press releases

Month Year

Email alerts

Mar 3, 2016

Medtronic the First to Offer Complete Portfolio of Full-Body MR Conditional Neurostimulation Systems for Chronic Pain

FDA Approval of Medtronic Specify® SureScan® MRI Surgical Leads Rounds Out Exclusive Portfolio Designed for Access to Full-Body MRI[*]

DUBLIN - March 3, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Specify® SureScan® MRI surgical leads, which are indicated for use as part...
Mar 1, 2016

HeartWare Presentation At The Raymond James 37th Annual Institutional Investors Conference To Be Webcast

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
Mar 1, 2016

Medtronic Reports Third Quarter Financial Results

Revenue of $6.9 Billion Grew 6% on a Comparable, Constant Currency Basis; 61% as Reported

DUBLIN - March 1, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2016, which ended January 29, 2016. Unless otherwise noted, all revenue...
Feb 25, 2016

HeartWare International Reports Fourth Quarter And Full-Year 2015 Financial Results

- Fourth Quarter 2015 Revenue of $68.1 Million

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
Feb 22, 2016

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

DUBLIN - February 22, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication trial for the CoreValve® Evolut® R System,...

Show per page